S. Yalcin Et Al. , "The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4, pp.311-316, 2015
Yalcin, S. Et Al. 2015. The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4 , 311-316.
Yalcin, S., MUTLU, P., Cetin, T., Sarper, M., Ozgur, G., & Avcu, F., (2015). The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4, 311-316.
Yalcin, Serap Et Al. "The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4, 311-316, 2015
Yalcin, Serap Et Al. "The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4, pp.311-316, 2015
Yalcin, S. Et Al. (2015) . "The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.4, pp.311-316.
@article{article, author={Serap Yalcin Et Al. }, title={The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2015, pages={311-316} }